Table of Contents [1–25 of 114 articles]

• Table of Contents for Year 2012
• AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral Therapy, Prakash Vishnu and David M. Aboulafia
  Volume 2012 (2012), Article ID 485943, 9 pages
• Improving TCR Gene Therapy for Treatment of Haematological Malignancies, Emma Nicholson, Sara Ghorashian, and Hans Stauss
  Volume 2012 (2012), Article ID 404081, 11 pages
• A Role for Bcl-2 in Notch1-Dependent Transcription in Thymic Lymphoma Cells, Ronit Vogt Sionov, Shlomit Kfir-Erenfeld, Rachel Spokoini, and Eitan Yefenof
  Volume 2012 (2012), Article ID 435241, 5 pages
• The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-Cell Lymphoma, Marco Gunnellini, Rita Emili, Stefano Coaccioli, and Anna Marina Liberati
  Volume 2012 (2012), Article ID 195484, 10 pages
• Nonengraftment Haploidentical Cellular Therapy for Hematologic Malignancies, John L. Reagan, Loren D. Fast, Eric S. Winer, Howard Safran, James N. Butera, and Peter J. Quesenberry
  Volume 2012 (2012), Article ID 784213, 6 pages
• Towards Curative Therapy in Burkitt Lymphoma: The Role of Early African Studies in Demonstrating the Value of Combination Therapy and CNS Prophylaxis, Ian Magrath
  Volume 2012 (2012), Article ID 130680, 7 pages
• HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART, Caron A. Jacobson and Jeremy S. Abramson
  Volume 2012 (2012), Article ID 507257, 8 pages
• In Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33+ Acute Myeloid Leukemia, A. Dutour, V. Marin, I. Pizzitola, S. Valsesia-Wittmann, D. Lee, E. Yvon, H. Finney, A. Lawson, M. Brenner, A. Biondi, E. Biagi, and R. Rousseau
  Volume 2012 (2012), Article ID 683065, 10 pages
• Molecular-Targeted Therapies for Hematologic Malignancies, Kevin D. Bunting, Cheng-Kui Qu, and Michael H. Tomasson
  Volume 2012 (2012), Article ID 606423, 2 pages
• Gab Adapter Proteins as Therapeutic Targets for Hematologic Disease, Sheetal Verma, Tamisha Vaughan, and Kevin D. Bunting
  Volume 2012 (2012), Article ID 380635, 10 pages
• Molecular Profiling of Aggressive Lymphomas, Maura Rossi, Maria Antonella Laginestra, Anna Gazzola, Maria Rosaria Sapienza, Stefano A. Pileri, and Pier Paolo Piccaluga
  Volume 2012 (2012), Article ID 464680, 9 pages
• HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era, J. A. Rodrigo, L. K. Hicks, M. C. Cheung, K. W. Song, H. Ezzat, C. S. Leger, J. Boro, J. S. G. Montaner, M. Harris, and H. A. Leitch
  Volume 2012 (2012), Article ID 735392, 9 pages
• Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia, Xiaoling Liu, Himalee Sabnis, Kevin D. Bunting, and Cheng-Kui Qu
  Volume 2012 (2012), Article ID 308252, 7 pages
• Extracellular NM23 Protein as a Therapeutic Target for Hematologic Malignancies, Junko Okabe-Kado, Takashi Kasukabe, and Yasuhiko Kaneko
  Volume 2012 (2012), Article ID 879368, 10 pages
• The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias, Flora Tzifi, Christina Economopoulou, Dimitrios Gourgiotis, Alexandros Ardavanis, Sotirios Papageorgiou, and Andreas Scorilas
  Volume 2012 (2012), Article ID 524308, 15 pages
• Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia, Philipp Koehler, Patrick Schmidt, Andreas A. Hombach, Michael Hallek, and Hinrich Abken
  Volume 2012 (2012), Article ID 595060, 13 pages
• Mutations in Epigenetic Modifiers in Myeloid Malignancies and the Prospect of Novel Epigenetic-Targeted Therapy, Amir T. Fathi and Omar Abdel-Wahab
  Volume 2012 (2012), Article ID 469592, 12 pages
• The Role of mTOR Inhibitors for the Treatment of B-Cell Lymphomas, Pinelopi Argyriou, Panagiota Economopoulou, and Sotirios Papageorgiou
  Volume 2012 (2012), Article ID 435342, 13 pages
• Table of Contents for Year 2011
• Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease, Yi Lin and William J. Hogan
  Volume 2011 (2011), Article ID 427863, 17 pages
• Long-Term Outcome after Autologous Stem Cell Transplantation with Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphoma and Myeloma Patients, Jan S. Moreb, Donya Salmasinia, Jack Hsu, Wei Hou, Christina Cline, and Emma Rosenau
  Volume 2011 (2011), Article ID 517561, 8 pages
• Obstetric Thromboprophylaxis: The Swedish Guidelines, Pelle G. Lindqvist and Margareta Hellgren
  Volume 2011 (2011), Article ID 157483, 6 pages
• Heme Oxygenase-1: A Critical Link between Iron Metabolism, Erythropoiesis, and Development, Stuart T. Fraser, Robyn G. Midwinter, Birgit S. Berger, and Roland Stocker
  Volume 2011 (2011), Article ID 473709, 6 pages
• Pathogenetic, Clinical, and Prognostic Features of Adult t(4;11)(q21;q23)/MLL-AF4 Positive B-Cell Acute Lymphoblastic Leukemia, F. Marchesi, K. Girardi, and G. Avvisati
  Volume 2011 (2011), Article ID 621627, 8 pages
• Expression of Thymidine Phosphorylase in Lymph Nodes Involved with Mycosis Fungoides and Sézary Syndrome, Xingcao Nie, Rekha Bhat, Essel Dulaimi Al-Saleem, Eric C. Vonderheid, and J. Steve Hou
  Volume 2011 (2011), Article ID 875135, 6 pages
• Molecular Diagnostics, Targeted Therapy, and the Indication for Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia, Anthony Oyekunle, Torsten Haferlach, Nicolaus Kröger, Evgeny Klyuchnikov, Axel Rolf Zander, Susanne Schnittger, and Ulrike Bacher
  Volume 2011 (2011), Article ID 154745, 8 pages